Laidou S, Grigoriadis D, Papanikolaou S, Foutadakis S, Ntoufa S, Tsagiopoulou M, Vatsellas G, Anagnostopoulos A, Kouvatsi A, Stavroyianni N, Psomopoulos F, Makris A M, Agelopoulos M, Thanos D, A. Chatzidimitriou, Papakonstantinou N, Stamatopoulos K.. The TΑp63/BCL2 axis represents a novel mechanism of clinical aggressiveness in chronic lymphocytic leukemia. Blood Advances 2022, vol. 6, no. 8, pp. 2646–2656; doi: 10.1182/bloodadvances.2021006348
